Literature DB >> 5014367

Immunologic unreactivity in bladder cancer patients.

C A Olsson, C N Rao, J O Menzoian, W E Byrd.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 5014367     DOI: 10.1016/s0022-5347(17)61090-5

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  7 in total

1.  Immunological characteristics of bladder cancer.

Authors: 
Journal:  Br Med J       Date:  1972-12-02

2.  Tumour markers in urology: aids in cancer diagnosis and management.

Authors:  B Wahren
Journal:  Urol Res       Date:  1979-06-22

3.  The Makari skin test and immunocompetence in bladder cancer.

Authors:  J R Masters; C C Rigby; K W Munson; D E Tee
Journal:  Urol Res       Date:  1980

4.  Analysis of natural killer activity and natural killer cell subsets in patients with bladder cancer.

Authors:  T Morita; A Tokue; N Minato
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

5.  Keyhole limpet hemocyanin immunotherapy of murine bladder cancer.

Authors:  D L Lamm; J I DeHaven; D R Riggs; C Delgra; R Burrell
Journal:  Urol Res       Date:  1993-01

6.  Immunological studies of anergic patients.

Authors:  D E Van Epps; J A Frierson; R C Williams
Journal:  Infect Immun       Date:  1974-11       Impact factor: 3.441

7.  Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer.

Authors:  Yuh-Shyan Tsai; Yeong-Chin Jou; Chun-Liang Tung; Chang-Te Lin; Cheng-Huang Shen; Syue-Yi Chen; Hsin-Tzu Tsai; Chen-Li Lai; Chao-Liang Wu; Tzong-Shin Tzai
Journal:  Virchows Arch       Date:  2014-04-15       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.